The role of follicular anti-Mullerian hormone in women undergoing IVF/ICSI with regard to size, oocyte presence, sociodemographic parameters, treatment variables, and other hormones and vitamins

References

• Wilson CA, Clemente ND, Ehrenfels C, et al. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily. Mol Endocrinol. 1993;7(2):247–257.
   PubMedGoogle Scholar
• Clemente ND, Jamin SP, Lugovskoy A, et al. Processing of anti-mullerian hormone regulates receptor activation by a mechanism distinct from TGF-beta. Mol Endocrinol. 2010;24(11):2193–2206.
   PubMedGoogle Scholar
• Lüllmann-Rauch R, Asan E. Taschenbuch histologie. Stuttgart (Germany); New York (NY): Georg Thieme Verlag; 2015. p. 545.
   Google Scholar
• Visser JA, Jong FHD, Laven JSE, et al. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction. 2006;131(1):1–9.
   PubMed Web of Science ®Google Scholar
• van Rooij IAJ, Broekmans FJM, Te Velde ER, et al. Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Human Reprod. 2002;17(12):3065–3071.
   PubMed Web of Science ®Google Scholar
• Müller A, Dittrich R, Reissmann C, et al. Rationelle diagnostik in der gynäkologischen endokrinologie und reproduktionsmedizin – teil 2: besondere aspekte der sterilitätsdiagnostik. Geburtsh Frauenheilk. 2009;69(07):R67–R88.
   Google Scholar
• Wunder DM, Guibourdenche J, Birkhäuser und MH, et al. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril. 2008;90(6):2203–2210.
   PubMed Web of Science ®Google Scholar
• Walters KA, Eid S, Edwards MC, et al. Steroid profiles by liquid chromatography-mass spectrometry of matched serum and single dominant ovarian follicular fluid from women undergoing IVF. Reprod Biomed Online. 2019;38(1):30–37.
   PubMed Web of Science ®Google Scholar
• Kim JH, Lee JR, Chang HJ, et al. Anti-Müllerian hormone levels in the follicular fluid of the preovulatory follicle: a predictor for oocyte fertilization and quality of embryo. J Korean Med Sci. 2014;29(9):1266–1270.
   PubMed Web of Science ®Google Scholar
• Sacha CR, Chavarro JE, Williams PL, et al. Follicular fluid anti-Müllerian hormone (AMH) concentrations and outcomes of in vitro fertilization cycles with fresh embryo transfer among women at a fertility center. J Assist Reprod Genet. 2020;37(11):2757–2766.
   PubMed Web of Science ®Google Scholar
• Lv Y, Du S, Huang und Hao XC. Follicular fluid estradiol is an improved predictor of in vitro fertilization/intracytoplasmic sperm injection and embryo transfer outcome. Exp Ther Med. 2020;20(6):1.
   PubMed Web of Science ®Google Scholar
• Schenk M, Kröpfl JM, Obermayer-Pietsch B, et al. Anti-Mullerian hormone concentrations in individual follicular fluids within one stimulated IVF cycle resemble blood serum values. J Assist Reprod Genet. 2017;34(9):1115–1120.
   PubMed Web of Science ®Google Scholar
• Merhi Z, Doswell A, Krebs K, et al. Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells. J Clin Endocrinol Metabol. 2014;99(6):E1137–E1145.
   PubMed Web of Science ®Google Scholar
• Bednarska-Czerwińska A, Olszak-Wąsik K, Olejek A, et al. Vitamin D and anti-Müllerian hormone levels in infertility treatment: the change-point problem. Nutrients. 2019;11(5):1053.
   Web of Science ®Google Scholar
• Skowrońska P, Kunicki M, Pastuszek E, et al. Vitamin D and anti-Müllerian hormone concentration in human follicular fluid individually aspirated from all patient follicles. Gynecol Endocrinol. 2021;5:1–5.
   Google Scholar
• Capkın Sİ, Ozyer S, Karayalçın R, et al. Serum and follicular fluid anti-Mullerian hormone concentrations at the time of follicle puncture and reproductive outcome. J Turkish German Gynecol Assoc. 2011;13(1):21–26.
   Google Scholar
• Takahashi C, Fujito A, Kazuka M, et al. Anti-Müllerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril. 2008;89(3):586–591.
   PubMed Web of Science ®Google Scholar
• Bastu E, Gokulu SG, Dural O, et al. The association between follicular fluid levels of cathepsin B, relaxin or AMH with clinical pregnancy rates in infertile patients. Euro J Obstetr Gynecol Reprod Biol. 2015;187:33–34.
   Web of Science ®Google Scholar
• Yding Andersen C, Rosendahl M, Byskov AG. Concentration of anti-Müllerian hormone and inhibin-B in relation to steroids and age in follicular fluid from small antral human follicles. J Clin Endocrinol Metabol. 2008;93(6):2344–2349.
   PubMed Web of Science ®Google Scholar
• Fanchin R, Louafi N, Méndez Lozano DH, et al. Per-follicle measurements indicate that anti-Müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status. Fertil Steril. 2005;84(1):167–173.
   PubMed Web of Science ®Google Scholar
• Kedem A, Hourvitz A, Yung Y, et al. Anti-Müllerian hormone (AMH) downregulation in late antral stages is impaired in PCOS patients. A study in normo-ovulatory and PCOS patients undergoing in vitro maturation (IVM) treatments. Gynecol Endocrinol. 2013;29(7):651–656.
   PubMed Web of Science ®Google Scholar
• Kristensen SG, Kumar A, Kalra B, et al. Quantitative differences in TGF-β family members measured in small antral follicle fluids from women with or without PCO. J Clin Endocrinol Metabol. 2019;104(12):6371–6384.
   PubMed Web of Science ®Google Scholar
• Bøtkjaer JA, Jeppesen JV, Wissing ML, et al. Pregnancy-associated plasma protein a in human ovarian follicles and its association with intrafollicular hormone levels. Fertil Steril. 2015;104(5):1294–1301.
   PubMed Web of Science ®Google Scholar
• Mamsen LS, Bøtkjaer JA, Kristensen SG, et al. High variability of molecular isoforms of AMH in follicular fluid and granulosa cells from human small antral follicles. Front Endocrinol. 2021;12:617523.
   PubMed Web of Science ®Google Scholar
• Melado Vidales L, Fernández-Nistal A, Martínez Fernández V, et al. Anti-Müllerian hormone levels to predict oocyte maturity and embryo quality during controlled ovarian hyperstimulation. Minerva Ginecologica. 2017;69(3):225–232.
   PubMed Web of Science ®Google Scholar
• Li Y, Nie M, Liu Y, et al. The dynamic changes of anti-Mullerian hormone and inhibin B during controlled ovarian hyperstimulation in decreased ovarian reserve women and the effect on clinical outcome. Gynecol Endocrinol. 2015;31(6):450–453.
   PubMed Web of Science ®Google Scholar
• Pinheiro JC. Conditional versus marginal covariance representation for linear adn nonlinear models. Austrian J Stat. 2006;35:31–44.
   Google Scholar
• R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing; 2014.
   Google Scholar
• Kedem A, Yung Y, Yerushalmi GM, et al. Anti müllerian hormone (AMH) level and expression in mural and cumulus cells in relation to age. J Ovarian Res. 2014;7(1):113.
   PubMedGoogle Scholar
• Leidenberger FA, Strowitzki T, Ortmann O. Klinische endokrinologie für frauenärzte. Berlin (Germany): Springer Berlin Heidelberg; 2014. pp. 373–376.
   Google Scholar
• Wolff MV, Stute P, Eisenhut M, et al. Serum and follicular fluid testosterone concentrations do not correlate, questioning the impact of androgen supplementation on the follicular endocrine milieu. Reprod Biomed Online. 2017;35(5):616–623.
   PubMed Web of Science ®Google Scholar
• Ciepiela P, Dulęba AJ, Kario A, et al. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer. Human Reprod. 2019;34(11):2244–2253.
   PubMed Web of Science ®Google Scholar
• Hohmann FP, Macklon NS, Fauser BCJM. A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long GnRH a. Human Reprod. 2003;88(1):166–173.
   Google Scholar
• Aydogan Mathyk B, Aslan Cetin B, Vardagli D, et al. Comparison of antagonist mild and long agonist protocols in terms of follicular fluid total antioxidant capacity. Taiwan J Obstet Gynecol. 2018;57(2):194–199.
   PubMed Web of Science ®Google Scholar
• Bolat SE, Ozdemirci S, Kasapoglu T, et al. The effect of serum and follicular fluid anti-Mullerian hormone level on the number of oocytes retrieved and rate of fertilization and clinical pregnancy. North Clin Istanbul. 2016;3(2):90–96.
   PubMed Web of Science ®Google Scholar
• Yilmaz N, Uygur D, Dogan M, et al. The effect of follicular anti-Mullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome. Gynecol Endocrinol. 2012;28(3):162–165.
   PubMed Web of Science ®Google Scholar
• Wang JG, Douglas NC, Nakhuda GS, et al. The association between anti-Müllerian hormone and IVF pregnancy outcomes is influenced by age. Reprod Biomed Online. 2010;21(6):757–761.
   PubMed Web of Science ®Google Scholar
• Hattori Y, Sato T, Okada H, et al. Comparison of follicular fluid and serum anti-Mullerian hormone levels as predictors of the outcome of assisted reproductive treatment. Euro J Obstetr Gynecol Reprod Biol. 2013;169(2):252–256.
   PubMed Web of Science ®Google Scholar